1. Create Account | Help
CURRENT ORDER
0 Items - Edit
Total: $000.00

Osteogenics Biomedical Introduces enCore® 50/50 Allograft

.

LUBBOCK, Texas – Osteogenics Biomedical, a leader in the development of innovative dental bone grafting products, introduces enCore® 50/50 Cortical and Cancellous Allograft to compliment the family of enCore® Allografts.

The 50/50 allograft combines space maintaining cortical bone with porous, faster resorbing cancellous bone in a single bottle. All lots of enCore® 50/50 Cortical & Cancellous allograft are sourced from a single donor.

In addition to the new 50/50 allograft, Osteogenics offers the popular enCore® 70/30 Combination allograft composed of mineralized cortical bone and osteoinductive demineralized matrix, as well as a 100 percent mineralized cortical allograft. All of the allografts are available in a variety of volume sizes to treat a wide range of bony defects and are processed by Allotech, an FDA-registered and AATB-accredited tissue bank.

For more information about enCore® Allografts, visit osteogenics.com, or contact a customer service representative at 888.796.1923.

About Osteogenics Biomedical:
Headquartered in Lubbock, Texas, Osteogenics Biomedical is a leader in the development of innovative dental bone grafting products serving Periodontists, Oral & Maxillofacial Surgeons and clinicians involved in regenerative and implant dentistry throughout the world. Osteogenics offers a complete line of bone grafting products including enCore® Combination and Mineralized Allografts, Cytoplast™ PTFE membranes, Cytoplast™ collagen membranes, Vitala™ porcine collagen membranes, Cytoplast™ PTFE suture, and the Pro-fix™ Precision Fixation System.

August 12, 2014

Copyright © 2009-16 Osteogenics Biomedical, All Rights Reserved.
Legal Statements | Customer Service Policies